cetirizine hydrochloride and pseudoephedrine hydrochloride

Generic: cetirizine hydrochloride, pseudoephedrine hydrochloride

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cetirizine hydrochloride and pseudoephedrine hydrochloride
Generic Name cetirizine hydrochloride, pseudoephedrine hydrochloride
Labeler padagis israel pharmaceuticals ltd
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

cetirizine hydrochloride 5 mg/1, pseudoephedrine hydrochloride 120 mg/1

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-147
Product ID 45802-147_1e179f00-1e00-4199-bf78-bb00aa268c74
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA210719
Listing Expiration 2026-12-31
Marketing Start 2020-03-31

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802147
Hyphenated Format 45802-147

Supplemental Identifiers

RxCUI
1014571
UNII
64O047KTOA 6V9V2RYJ8N

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cetirizine hydrochloride and pseudoephedrine hydrochloride (source: ndc)
Generic Name cetirizine hydrochloride, pseudoephedrine hydrochloride (source: ndc)
Application Number ANDA210719 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 120 mg/1
source: ndc
Packaging
  • 12 BLISTER PACK in 1 CARTON (45802-147-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
  • 24 BLISTER PACK in 1 CARTON (45802-147-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
source: ndc

Packages (2)

Ingredients (2)

cetirizine hydrochloride (5 mg/1) pseudoephedrine hydrochloride (120 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1e179f00-1e00-4199-bf78-bb00aa268c74", "openfda": {"unii": ["64O047KTOA", "6V9V2RYJ8N"], "rxcui": ["1014571"], "spl_set_id": ["3260111b-35da-4f95-8081-51eae4b1ef45"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BLISTER PACK in 1 CARTON (45802-147-53)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-53", "marketing_start_date": "20200331"}, {"sample": false, "description": "24 BLISTER PACK in 1 CARTON (45802-147-62)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-62", "marketing_start_date": "20200331"}], "brand_name": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "product_id": "45802-147_1e179f00-1e00-4199-bf78-bb00aa268c74", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "45802-147", "generic_name": "Cetirizine hydrochloride, Pseudoephedrine hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA210719", "marketing_category": "ANDA", "marketing_start_date": "20200331", "listing_expiration_date": "20261231"}